NASDAQ:NH NantHealth (NH) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free NH Stock Alerts $0.41 -0.19 (-31.67%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.41▼$0.4150-Day Range$0.29▼$0.6952-Week Range$1.24▼$9.75Volume145 shsAverage Volume38,073 shsMarket Capitalization$3.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaSustainability Get NantHealth alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About NantHealth Stock (NASDAQ:NH)NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.Read More NH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NH Stock News HeadlinesApril 24, 2024 | americanbankingnews.comNantHealth (NASDAQ:NH) Earns Hold Rating from Analysts at StockNews.comApril 23, 2024 | travel.usnews.com13 Most Romantic Getaways in New HampshireApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 23, 2024 | businesswire.comNantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive TeamApril 16, 2024 | americanbankingnews.comNantHealth (NASDAQ:NH) Now Covered by StockNews.comApril 10, 2024 | finance.yahoo.comNantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare TechnologyApril 10, 2024 | businesswire.comNantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare TechnologyFebruary 18, 2024 | usatoday.comWill Nikki Haley give Donald Trump a run for his money in one-of-a-kind NH primary?April 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.January 21, 2024 | usnews.comWhat to Know About New Hampshire Before the PrimaryJanuary 6, 2024 | nypost.comNikki Haley slammed after saying NH voters ‘correct’ Iowa resultsJanuary 5, 2024 | foxnews.comFather of slain New Hampshire girl orchestrated savage plot to hide heinous crime: prosecutorsDecember 27, 2023 | nypost.comChris Christie’s time, temper grows short in New HampshireDecember 15, 2023 | usnews.comBest New Hampshire High SchoolsNovember 24, 2023 | usatoday.comRon DeSantis slipping: Falls further behind Donald Trump and Nikki Haley in New HampshireNovember 24, 2023 | usatoday.comNH schedules its first-in-the nation primary, despite an ongoing battle with DemocratsNovember 22, 2023 | theguardian.comGunman in fatal New Hampshire hospital shooting identifiedNovember 21, 2023 | theguardian.comNew Hampshire police yet to identify suspect in fatal hospital shootingNovember 7, 2023 | usatoday.comNikki Haley is making Vivek Ramaswamy her foreign policy foil. And New Hampshire voters are into it.October 24, 2023 | usatoday.comNikki Haley tells N.H. voters why Trump shouldn't be the president: 'Leave the negativity and chaos'October 18, 2023 | usatoday.comNew Hampshire debate watchers have a message for Chris Christie: Get off the island - PollOctober 14, 2023 | cbsnews.comRon DeSantis to file for New Hampshire primary ThursdayOctober 12, 2023 | usatoday.comPilot identified in fatal Croydon, New Hampshire helicopter crashSeptember 7, 2023 | usatoday.comMom drowns while trying to save her 10-year-old son at Franconia Falls in New HampshireSeptember 7, 2023 | usatoday.comMan drowns trying to rescue wife, her son in fast-moving New Hampshire riverSeptember 6, 2023 | foxnews.comNew Hampshire Democrats defy Biden, DNC ultimatum to ditch first-in-nation primary: 'embarrassing situation'August 26, 2023 | foxnews.comNew Hampshire sheriff placed on paid administrative leave after being accused of stealing county fundsSee More Headlines Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Data processing & preparation Sub-IndustryN/A Current SymbolNASDAQ:NH Previous SymbolNYSE:NH CUSIPN/A CIK1566469 Webwww.nanthealth.com Phone(855) 949-6268FaxN/AEmployees326Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($7.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-67,780,000.00 Net Margins-94.67% Pretax Margin-95.06% Return on EquityN/A Return on Assets-39.82% Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.64 Sales & Book Value Annual Sales$67.68 million Price / Sales0.07 Cash FlowN/A Price / Cash FlowN/A Book Value($30.72) per share Price / Book-0.02Miscellaneous Outstanding Shares7,703,000Free Float2,981,000Market Cap$4.62 million OptionableNot Optionable Beta1.82 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesR. Harris NaseemChief Executive Officer & DirectorBob PetrouChief Financial OfficerTiffany AveryChief Medical OfficerBrandon VillerySecretary, Senior Vice President & General CounselRonald Allen LouksChief Strategy & Development OfficerKey CompetitorsProSomnusNASDAQ:OSAPAraviveNASDAQ:ARAVAridis PharmaceuticalsNASDAQ:ARDSNemaura MedicalNASDAQ:NMRDAvalon GloboCareNASDAQ:ALBTView All Competitors NH Stock Analysis - Frequently Asked Questions How have NH shares performed in 2024? NantHealth's stock was trading at $0.43 at the beginning of the year. Since then, NH shares have increased by 39.5% and is now trading at $0.60. View the best growth stocks for 2024 here. How were NantHealth's earnings last quarter? NantHealth, Inc. (NASDAQ:NH) posted its earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. The business had revenue of $14.36 million for the quarter, compared to analysts' expectations of $17.70 million. During the same quarter last year, the company posted ($0.08) EPS. What is Patrick Soon-Shiong's approval rating as NantHealth's CEO? 82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of NantHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX). When did NantHealth IPO? NantHealth (NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers. How do I buy shares of NantHealth? Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
